Adnkronos The multidisciplinary approach "is particularly crucial due to the characteristics of this tumor," hepatocellular carcinoma, "which affects a vital organ whose damage can lead to death just as much as the cancer itself. In the most advanced cases, we have highly effective systemic therapies that we often combine or integrate sequentially with local-regional treatments. This is why it is essential for specialists to sit at the same table to define the best solution for each individual patient."
This was stated by Fabio Piscaglia, Professor of Internal Medicine at the University of Bologna and Director of Internal Medicine, Hepatobiliary and Immunoallergological Diseases at the IRCCS AOU of Bologna, at the media tutorial on new frontiers in liver cancer treatment, organized in Milan and promoted by AstraZeneca.
https://www.youtube.com/watch?v=qWcVNQFpIHQ